Stock Track | Alvotech Soars 6.13% in Pre-Market After Clearing Key FDA Inspection

Stock Track

05/11

Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.

The price movement comes after the company announced that the U.S. Food and Drug Administration has completed a routine cGMP surveillance inspection of its manufacturing facility in Reykjavik, Iceland. The FDA concluded the inspection and issued a Form 483, but Alvotech stated that the observations can be addressed quickly and do not raise any substantial issues with the site or its operations.

This positive inspection outcome positions Alvotech to resubmit its relevant Biologics License Applications (BLAs) in the current quarter. The company continues to expect FDA approval for these biosimilar candidates during 2026, marking a crucial step forward for its product pipeline.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1168707808"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1168707808\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1168707808?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-11 21:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168707808","market":"nz","top_or_hot":-1,"title":"Stock Track | Alvotech Soars 6.13% in Pre-Market After Clearing Key FDA Inspection","media":"Stock Track","content":"<p>Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.</p><p>The price movement comes after the company announced that the U.S. Food and Drug Administration has completed a routine cGMP surveillance inspection of its manufacturing facility in Reykjavik, Iceland. The FDA concluded the inspection and issued a Form 483, but Alvotech stated that the observations can be addressed quickly and do not raise any substantial issues with the site or its operations.</p><p>This positive inspection outcome positions Alvotech to resubmit its relevant Biologics License Applications (BLAs) in the current quarter. The company continues to expect FDA approval for these biosimilar candidates during 2026, marking a crucial step forward for its product pipeline.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Alvotech Soars 6.13% in Pre-Market After Clearing Key FDA Inspection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Alvotech Soars 6.13% in Pre-Market After Clearing Key FDA Inspection\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-05-11 21:12</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.</p><p>The price movement comes after the company announced that the U.S. Food and Drug Administration has completed a routine cGMP surveillance inspection of its manufacturing facility in Reykjavik, Iceland. The FDA concluded the inspection and issued a Form 483, but Alvotech stated that the observations can be addressed quickly and do not raise any substantial issues with the site or its operations.</p><p>This positive inspection outcome positions Alvotech to resubmit its relevant Biologics License Applications (BLAs) in the current quarter. The company continues to expect FDA approval for these biosimilar candidates during 2026, marking a crucial step forward for its product pipeline.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALVO","symbol_name":"Alvotech","start_time":0,"source_url":"","article_id":"1168707808","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168707808","pubTimestamp":1778505177,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.The price movement comes after the company announced that the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALVO":"Alvotech"},"translate_title":"个股追踪|Alvotech通过FDA关键检查后盘前大涨6.13%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALVO":1},"content_text":"Alvotech's stock surged 6.13% in pre-market trading on Monday, following a significant regulatory update from the biosimilar developer.The price movement comes after the company announced that the U.S. Food and Drug Administration has completed a routine cGMP surveillance inspection of its manufacturing facility in Reykjavik, Iceland. The FDA concluded the inspection and issued a Form 483, but Alvotech stated that the observations can be addressed quickly and do not raise any substantial issues with the site or its operations.This positive inspection outcome positions Alvotech to resubmit its relevant Biologics License Applications (BLAs) in the current quarter. The company continues to expect FDA approval for these biosimilar candidates during 2026, marking a crucial step forward for its product pipeline.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}